{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:22:05Z","timestamp":1770510125689,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.083","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T14:51:22Z","timestamp":1305211882000},"page":"4778-4784","source":"Crossref","is-referenced-by-count":31,"title":["Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"J. Hellen","family":"Amuguni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn O.","family":"Kerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris R.","family":"Belitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald T.","family":"Keusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham L.","family":"Sonenshein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul","family":"Tzipori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2011.04.083_bib0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2011.04.083_bib0010","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/CVI.00135-10","article-title":"Development of a Bacillus subtilis-based rotavirus vaccine","volume":"17","author":"Lee","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.04.083_bib0015","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/j.vaccine.2010.08.016","article-title":"Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.083_bib0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.1997.13.945","article-title":"Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses","volume":"13","author":"Staats","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.083_bib0025","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/491739","article-title":"Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines","volume":"192","author":"Armstrong","year":"2005","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2011.04.083_bib0030","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2011.04.083_bib0035","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2011.04.083_bib0040","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.083_bib0045","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C","article-title":"Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant","volume":"32","author":"BenMohamed","year":"2002","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.083_bib0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","article-title":"Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications","volume":"41","author":"Zhang","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"51","key":"10.1016\/j.vaccine.2011.04.083_bib0055","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"Cuburu","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.083_bib0060","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.083_bib0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.398","article-title":"New generation of mucosal adjuvants for the induction of protective immunity","volume":"13","author":"Yuki","year":"2003","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.083_bib0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.femsre.2004.12.001","article-title":"The use of bacterial spore formers as probiotics","volume":"29","author":"Hong","year":"2005","journal-title":"FEMS Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.083_bib0075","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1128\/AEM.65.9.4288-4291.1999","article-title":"Characterization of two Bacillus probiotics","volume":"65","author":"Green","year":"1999","journal-title":"Appl Environ Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.04.083_bib0080","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0264-410X(03)00207-X","article-title":"Bacillus spores for vaccine delivery","volume":"21","author":"Oggioni","year":"2003","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2011.04.083_bib0085","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2010.04.013","article-title":"Persistence of mucosal and systemic immune responses following sublingual immunization","volume":"28","author":"Negri","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T03:14:43Z","timestamp":1592536483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":17,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11006384"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}